ClinicalTrials.Veeva

Menu

Effect of Laser Puncture Versus Ultraviolet Radiation on Women With Polycystic Ovarian Syndrome

Cairo University (CU) logo

Cairo University (CU)

Status

Enrolling

Conditions

Polycystic Ovary Syndrome

Treatments

Drug: Metformin
Device: ultraviolet radiatio
Device: aser puncture

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Obese women with polycystic ovarian syndrome aged between 25 and 35 years old will be divided into three groups. For three months, group (A) will receive laser puncture (3 sessions per week), along with a metformin supplementation, group (B) will receive ultraviolet radiation (3 sessions per week), along with a metformin supplementation, while group (C) will receive only metformin supplementation. The follicular size will be measured using ultrasound, while, female sex hormones, and serum 25-hydroxyvitamin D levels will bel evaluated using blood analysis

Full description

Obese women with polycystic ovarian syndrome aged between 25 and 35 years old will be divided into three groups. For three months, group (A) will receive laser puncture (3 sessions per week), along with a metformin supplementation, group (B) will receive ultraviolet radiation (3 sessions per week), along with a metformin supplementation, while group (C) will receive only metformin supplementation. The follicular size will be measured using ultrasound, while, female sex hormones, and serum 25-hydroxyvitamin D levels will bel evaluated using blood analysis

Enrollment

100 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obese nulli gravid PCOS women
  • BMI 30-40 kg/m2

Exclusion criteria

  • hyperprolactinemia
  • BMI > 40 kg/m2 Endocrinological disorders such as thyroid disease, Cushing's syndrome, Coagulopathy
  • Recent use of oral contraceptive pills
  • Recent use of any photosensitizing medications, such as aspirin, tetracycline, chlorothiazide, or psoralen suspicious of neoplasms

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 3 patient groups

laser puncture group
Active Comparator group
Description:
gallium Arsenide infrared (GaAlAs) laser, using a wavelength at 904nm with a Maximum power output is 150 mW and a power density at 0.417 W/cm2 as well as an energy density of 4 J/cm2 will be employed for 2 minutes on specific acupuncture points
Treatment:
Device: aser puncture
Drug: Metformin
Ultraviolet treatment group
Active Comparator group
Description:
The therapist will place the UV arc lamp at a height of 60 to 80 cm above the lower abdomen region, perpendicular to the skin. Each woman's lamp will be switched on and given an individual timer by the minimum effective dose
Treatment:
Drug: Metformin
Device: ultraviolet radiatio
Metformin only group
Active Comparator group
Treatment:
Drug: Metformin

Trial contacts and locations

1

Loading...

Central trial contact

Wafaa Kamal; Ahmed M Maged

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems